SIRONA CLINICAL TRIAL
Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trialPatients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than ...
Good Glamm misses payroll again; Uber top-deck reshuffleCash-strapped beauty platform Good Glamm Group did not pay wages for the second month in a row. This and more in today’s ETtech Top 5.
- Load More